An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional study
Therapeutic Advances in Hematology
Published online on March 11, 2026
Abstract
Therapeutic Advances in Hematology, Volume 17, January-December 2026.
Background:Severe hemophilia traditionally requires lifelong prophylactic treatment, which cannot fully prevent joint damage and significantly impacts patients’ quality of life. In recent years, gene therapy has been extensively researched as a potential ...
Background:Severe hemophilia traditionally requires lifelong prophylactic treatment, which cannot fully prevent joint damage and significantly impacts patients’ quality of life. In recent years, gene therapy has been extensively researched as a potential ...